These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7608324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J, Freeman R, Frishman W.
    J Clin Pharmacol; 1995 Jan; 35(1):1-16. PubMed ID: 7751408
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Hormone replacement therapy for prevention in postmenopausal women: the end of controversy?].
    Balasch J.
    Med Clin (Barc); 2002 Oct 05; 119(11):416-7. PubMed ID: 12381276
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A.
    Climacteric; 2018 Aug 05; 21(4):321-325. PubMed ID: 29583028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Indications for hormone replacement therapy].
    Birkhäuser MH.
    Ther Umsch; 2000 Oct 05; 57(10):635-42. PubMed ID: 11081375
    [Abstract] [Full Text] [Related]

  • 12. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD.
    Compr Ther; 1994 Oct 05; 20(10):580-5. PubMed ID: 7859441
    [No Abstract] [Full Text] [Related]

  • 13. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb 07; 275(5):370-5. PubMed ID: 8569016
    [Abstract] [Full Text] [Related]

  • 14. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M, Simoncini T, Fuller S, Genazzani AR.
    Maturitas; 2008 Feb 07; 60(3-4):185-201. PubMed ID: 18775609
    [Abstract] [Full Text] [Related]

  • 15. Postmenopausal hormone replacement therapy--clinical implications.
    Ravn SH, Rosenberg J, Bostofte E.
    Eur J Obstet Gynecol Reprod Biol; 1994 Feb 07; 53(2):81-93. PubMed ID: 8194655
    [Abstract] [Full Text] [Related]

  • 16. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE.
    N Engl J Med; 1995 Jun 15; 332(24):1589-93. PubMed ID: 7753136
    [Abstract] [Full Text] [Related]

  • 17. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C.
    Recenti Prog Med; 2001 Mar 15; 92(3):209-12. PubMed ID: 11320854
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Hormone replacement therapy and cardiovascular risk].
    Maffei S, De Caterina R.
    G Ital Cardiol; 1996 Aug 15; 26(8):899-940. PubMed ID: 9005173
    [Abstract] [Full Text] [Related]

  • 20. Risk assessment of the menopausal patient.
    Kothari S, Thacker HL.
    Med Clin North Am; 1999 Nov 15; 83(6):1489-502. PubMed ID: 10584604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.